Live with Leadership with Dr. Carl Dieffenbach Now Available
2-16-2021On Thursday, February 4th, the Office of Infectious Disease and HIV/AIDS Policy (OIDP) held the first Live with Leadership conversation of 2021 with an exciting…
Prevention
Best Practices: Interventions for PrEP
2-11-2021The Centers for Disease Control and Prevention (CDC HIV/AIDS Prevention Research Synthesis (PRS) Project) identifies evidence-based interventions (EBIs) and evi…
New SAMHSA Guide Highlights HIV Prevention and Treatment for People with Substance Use and/or Mental Disorders
2-3-2021The HHS Substance Abuse and Mental Health Services Administration (SAMHSA) has released Prevention and Treatment of HIV Among People Living with Substance Use a…
New CDC Resource: HIV Prevention in the United States: Mobilizing to End the Epidemic
2-2-2021As the nation’s lead HIV prevention agency, CDC is working with partners to achieve dramatic new declines in HIV infections. In part with new resources ma…
Antibody Infusions Prevent Acquisition of Some HIV Strains, NIH Studies Find
1-26-2021#HIVPrevention NEWS from @NIAIDnews: Infusions of an anti-HIV #antibody prevented acquisition of #HIV strains sensitive to that antibody, but did not significan…
Ready, Set, PrEP
1-25-2021Ready, Set, PrEP is a nationwide program that makes PrEP medications available at no cost to individuals who lack prescription drug coverage. Although more than…
Save the Date – Live with Leadership HIV Research for Prevention Conference
1-22-2021On Thursday, February 4th the Office of Infectious Disease and HIV/AIDS Policy (OIDP) will kick off the first Live with Leadership conversation in 2021 with an …
Long-Acting HIV Prevention Tools
12-10-2020Scientist are working to develop long-acting forms of HIV prevention. Learn more.
NIH Announces Restructured HIV Clinical Trials Networks
12-3-2020Cross-posted from NIAID NewsroomGrant Awards Set Stage for Next Seven Years of Science-Driven HIV Clinical ResearchThe National Institute of Allergy and Infec…
NIH Study Finds Long-Acting Injectable Drug Prevents HIV Acquisition in Cisgender Women
11-9-2020Cross-posted from NIAID NewsroomLong-Acting Regimen More Effective than Daily Oral Pill Among African WomenA pre-exposure prophylaxis (PrEP) regimen containing …